🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Scott Hofsess

Novartis (Switzerland)

ORCID: 0000-0002-8465-4065

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Antibody–Drug Conjugate Sacituzumab Govitecan Drives Efficient Tissue Penetration and Rapid Intracellular Drug Release”.

Antibody–Drug Conjugate Sacituzumab Govitecan Drives Efficient Tissue Penetration and Rapid Intracellular Drug Release

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-22-0375

N/A

0DataRank · unranked

94 citations

Scott Hofsess, Thomas M. Cardillo, Serengulam V. Govindan, Jennifer Donnell, Greg M. Thurber +1 more

Improving Intracellular Delivery of an Antibody–Drug Conjugate Targeting Carcinoembryonic Antigen Increases Efficacy at Clinically Relevant Doses In Vivo

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0437

N/A

0DataRank · unranked

15 citations

Baron Rubahamya, Anna Kopp, Scott Hofsess, Thomas M. Cardillo, Nalini Sathyanarayan +4 more

Distinct effects of sacituzumab govitecan and berzosertib on DNA damage response in ovarian cancer

iScience(2024)10.1016/j.isci.2024.111283

N/A

0DataRank · unranked

7 citations

Tzu‐Ting Huang, Anu D. Sunkara, Margaret R. Pruitt, Kristen R. Ibanez, Chih-Yuan Chiang +6 more